Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1

被引:0
|
作者
Kaobin Ouyang
Dan Xie
Haojie Liao
Ying He
Hailin Xiong
机构
[1] Huizhou Municipal Central Hospital of Guangdong Province,Department of Medical Oncology
关键词
NSCLC; circ_0001786; miR-34b-5p; SRSF1; Gefitinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1 (vol 19, 178, 2024)
    Ouyang, Kaobin
    Xie, Dan
    Liao, Haojie
    He, Ying
    Xiong, Hailin
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [2] Circ_0006006 facilitates non-small cell lung cancer progression by modulating miR-924/SRSF7 axis
    Xu, Qinfu
    Shi, Jiang
    Zhang, Long
    Sheng, Yanbing
    Zhang, Yang
    Chu, Dan
    Xu, Aiguo
    JOURNAL OF GENE MEDICINE, 2022, 24 (05):
  • [3] Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway
    Niu, Rong
    Li, Dong
    Chen, Jian
    Zhao, Wentao
    CELL CYCLE, 2022, 21 (01) : 86 - 100
  • [4] Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axis
    Ding, Li
    Feng, Yinan
    Li, Longguang
    CELL CYCLE, 2022, 21 (22) : 2433 - 2443
  • [5] Circ_0006006 promotes the non-small cell lung cancer progression via modulating the miR-155-5p/ETS1 axis
    Teng, L. W.
    Zhang, G. F.
    Chen, H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (06): : 1991 - 1998
  • [6] miR-145-5p Modulates Gefitinib Resistance by Targeting NRAS and MEST in Non-Small Cell Lung Cancer
    Yu, Chuigong
    Li, Bingqing
    Wang, Jinghao
    Zhang, Ziyue
    Li, Shengjing
    Lei, Shixiong
    Wang, Qinhao
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 625 - 637
  • [7] circ_0114866 promotes the progression and EMT of non-small cell lung cancer via miR-653-5p/MYL6B axis
    Sun, Jinpeng
    Zhang, Zhenshan
    Xia, Binghui
    Yao, Tianyu
    Ge, Fengyue
    Yan, Fengmei
    HELIYON, 2024, 10 (17)
  • [8] Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis
    Yu, Xin
    Fu, Xueyan
    Zhang, Xia
    Bai, Changcai
    Wang, Yang
    ANTI-CANCER DRUGS, 2022, 33 (02) : 158 - 166
  • [9] Circ_0007432 promotes non-small cell lung cancer progression and macrophage M2 polarization through SRSF1/KLF12 axis
    Mao, Shanshan
    Wu, Dongyu
    Cheng, Xiaozhen
    Wu, Jinsheng
    ISCIENCE, 2024, 27 (06)
  • [10] circ-ATAD1 as Competing Endogenous RNA for miR-191-5p Forces Non-small Cell Lung Cancer Progression
    Wan, Zhihua
    Jia, Shanshan
    Lu, Junhua
    Ge, Xiangjing
    Chen, Qinghua
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (08) : 5099 - 5113